supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
N(6)-Carboxymethyllysine
drug:
Dasatinib
Research Papers that Mention the Interaction
“We showed that patients with CML‐CP treated with dasatinib can be stratified according to the early treatment response as determined by the halving time of BCR‐ABL1 transcripts.”
Shorter halving time of BCR‐ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic‐phase chronic myeloid leukemia treated with dasatinib: Results of the D‐first study of Kanto CML study group
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback